Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Transboundary and Emerging Diseases
|
December 6, 2017
Foot-and-mouth disease virus transmission dynamics and persistence in a herd of vaccinated dairy cattle in India
S S Hayer, K VanderWaal, R Ranjan, et al.
The Journal of the Association of Physicians of India
|
September 28, 2001
A multicentric study with arteether in patients of uncomplicated falciparum malaria
O P Asthana, J S Srivastava, V P Kamboj, et al.
Blood
|
May 20, 2024
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma
Ola Landgren, Thomas J Prior, Tara Masterson, et al.
Lancet (London, England)
|
December 15, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Transboundary and Emerging Diseases
|
December 6, 2017
Foot-and-mouth disease virus transmission dynamics and persistence in a herd of vaccinated dairy cattle in India
S S Hayer, K VanderWaal, R Ranjan, et al.
The Journal of the Association of Physicians of India
|
September 28, 2001
A multicentric study with arteether in patients of uncomplicated falciparum malaria
O P Asthana, J S Srivastava, V P Kamboj, et al.
Blood
|
May 20, 2024
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma
Ola Landgren, Thomas J Prior, Tara Masterson, et al.
Lancet (London, England)
|
December 15, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, et al.
Page
of 7